US Stock MarketDetailed Quotes

Edwards Lifesciences (EW)

Watchlist
  • 84.150
  • +4.430+5.56%
Close Apr 24 16:00 ET
  • 84.150
  • 0.0000.00%
Post 20:01 ET
48.52BMarket Cap44.76P/E (TTM)

Edwards Lifesciences (EW) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
11.55%6.07B
13.26%1.57B
14.67%1.55B
11.89%1.53B
6.23%1.41B
8.57%5.44B
9.43%1.39B
8.93%1.35B
5.70%1.37B
-8.89%1.33B
Operating revenue
11.55%6.07B
13.26%1.57B
14.67%1.55B
11.89%1.53B
6.23%1.41B
8.57%5.44B
9.43%1.39B
8.93%1.35B
5.70%1.37B
-8.89%1.33B
Cost of revenue
19.39%1.33B
17.39%343M
31.30%345.2M
25.01%344.4M
5.12%301.6M
14.22%1.12B
16.41%292.2M
4.91%262.9M
7.24%275.5M
-12.93%286.9M
Gross profit
9.52%4.73B
12.16%1.23B
10.66%1.21B
8.58%1.19B
6.53%1.11B
7.20%4.32B
7.70%1.09B
9.94%1.09B
5.32%1.09B
-7.71%1.04B
Operating expense
8.98%3.1B
15.67%856.3M
12.28%782.8M
5.23%756.9M
2.35%701.2M
11.65%2.84B
12.39%740.3M
11.61%697.2M
9.97%719.3M
-1.78%685.1M
Selling and administrative expenses
16.54%2.09B
22.57%602.9M
22.12%514.6M
12.18%502M
8.71%465.7M
13.06%1.79B
18.07%491.9M
10.34%421.4M
9.04%447.5M
-1.81%428.4M
Research and development costs
2.49%1.08B
-1.25%267.7M
10.77%280.7M
1.62%276.2M
-0.82%254.6M
9.36%1.05B
11.98%271.1M
4.37%253.4M
11.53%271.8M
-1.72%256.7M
Other operating expenses
-22,300.00%-67.2M
37.00%-14.3M
-155.80%-12.5M
---21.3M
---19.1M
---300K
---22.7M
--22.4M
----
----
Operating profit
10.55%1.64B
4.81%370.3M
7.81%425.1M
15.03%430.9M
14.53%409.9M
-0.41%1.48B
-0.95%353.3M
7.12%394.3M
-2.57%374.6M
-17.27%357.9M
Net non-operating interest income expense
47.66%148.4M
-18.78%35.9M
58.85%38.6M
141.29%37.4M
121.21%36.5M
102.62%100.5M
163.10%44.2M
60.93%24.3M
70.33%15.5M
91.86%16.5M
Non-operating interest income
40.32%168.8M
-12.03%56.3M
58.85%38.6M
141.29%37.4M
----
79.02%120.3M
86.05%64M
60.93%24.3M
70.33%15.5M
----
Non-operating interest expense
3.03%20.4M
----
----
----
----
12.50%19.8M
----
----
----
----
Total other finance cost
----
----
----
----
-121.21%-36.5M
----
----
----
----
-91.86%-16.5M
Other net income (expense)
-1,474.46%-511.7M
-4,167.57%-315.8M
-629.75%-115.3M
-1,016.39%-68.1M
-290.63%-12.5M
80.11%-32.5M
-17.46%-7.4M
-459.09%-15.8M
94.85%-6.1M
92.49%-3.2M
Gain on sale of security
-93.50%4M
----
----
----
----
561.29%61.5M
----
----
----
----
Special income (charges)
-411.74%-518.9M
-683.78%-319M
-170.02%-118M
-724.69%-66.8M
-69.66%-15.1M
42.81%-101.4M
-311.11%-40.7M
-1,886.36%-43.7M
93.31%-8.1M
79.86%-8.9M
-Less:Restructuring and merger&acquisition
-89.18%6.6M
-62.28%10.6M
-137.69%-12.4M
--4.2M
--4.2M
332.82%61M
--28.1M
--32.9M
--0
--0
-Less:Impairment of capital assets
--40M
--0
--40M
----
----
--0
--0
--0
----
----
-Less:Other special charges
705.45%325.4M
1,555.56%208.6M
737.04%90.4M
91.36%15.5M
22.47%10.9M
-80.15%40.4M
27.27%12.6M
390.91%10.8M
-94.52%8.1M
-79.54%8.9M
-Write off
--146.9M
--99.8M
--0
--47.1M
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
-56.76%3.2M
97.16%-800K
-90.32%2.7M
-165.00%-1.3M
-54.39%2.6M
60.87%7.4M
-394.74%-28.2M
322.73%27.9M
-20.00%2M
256.25%5.7M
Income before tax
-17.78%1.27B
-76.83%90.4M
-13.51%348.4M
4.22%400.2M
16.89%433.9M
12.80%1.55B
6.24%390.1M
3.92%402.8M
39.59%384M
-6.87%371.2M
Income tax
42.60%216.9M
-41.91%26.2M
37.84%56.1M
221.50%64.3M
51.84%70.3M
-0.20%152.1M
32.26%45.1M
-22.77%40.7M
-4.31%20M
-20.31%46.3M
Net income
-74.35%1.07B
-76.27%91.2M
-90.54%290.3M
-9.18%331.5M
1.54%356.4M
197.96%4.17B
3.95%384.3M
699.95%3.07B
19.48%365M
3.08%351M
Net income continuous Operations
-24.36%1.06B
-81.39%64.2M
-19.28%292.3M
-7.72%335.9M
11.91%363.6M
14.43%1.4B
3.57%345M
8.12%362.1M
43.19%364M
-4.58%324.9M
Net income discontinuous operations
-99.52%13.4M
-31.30%27M
-100.07%-2M
-540.00%-4.4M
-127.59%-7.2M
1,446.10%2.77B
7.38%39.3M
5,447.75%2.71B
-98.05%1M
--26.1M
Minority interest income
16.33%-4.1M
0
42.86%-800K
30.77%1.7M
-77.78%-1.6M
-63.33%-4.9M
-550.00%-1.3M
-16.67%-1.4M
181.25%1.3M
-900K
Net income attributable to the parent company
-74.28%1.07B
-76.35%91.2M
-90.52%291.1M
-9.32%329.8M
1.73%358M
197.68%4.17B
4.24%385.6M
697.82%3.07B
18.43%363.7M
3.35%351.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-74.28%1.07B
-76.35%91.2M
-90.52%291.1M
-9.32%329.8M
1.73%358M
197.68%4.17B
4.24%385.6M
697.82%3.07B
18.43%363.7M
3.35%351.9M
Basic earnings per share
-73.64%1.84
-75.38%0.16
-90.27%0.5
-6.56%0.57
5.17%0.61
202.16%6.98
6.56%0.65
715.87%5.14
19.61%0.61
3.57%0.58
Diluted earnings per share
-73.74%1.83
-75.38%0.16
-90.25%0.5
-6.56%0.57
5.17%0.61
203.04%6.97
6.56%0.65
714.29%5.13
22.00%0.61
3.57%0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 11.55%6.07B13.26%1.57B14.67%1.55B11.89%1.53B6.23%1.41B8.57%5.44B9.43%1.39B8.93%1.35B5.70%1.37B-8.89%1.33B
Operating revenue 11.55%6.07B13.26%1.57B14.67%1.55B11.89%1.53B6.23%1.41B8.57%5.44B9.43%1.39B8.93%1.35B5.70%1.37B-8.89%1.33B
Cost of revenue 19.39%1.33B17.39%343M31.30%345.2M25.01%344.4M5.12%301.6M14.22%1.12B16.41%292.2M4.91%262.9M7.24%275.5M-12.93%286.9M
Gross profit 9.52%4.73B12.16%1.23B10.66%1.21B8.58%1.19B6.53%1.11B7.20%4.32B7.70%1.09B9.94%1.09B5.32%1.09B-7.71%1.04B
Operating expense 8.98%3.1B15.67%856.3M12.28%782.8M5.23%756.9M2.35%701.2M11.65%2.84B12.39%740.3M11.61%697.2M9.97%719.3M-1.78%685.1M
Selling and administrative expenses 16.54%2.09B22.57%602.9M22.12%514.6M12.18%502M8.71%465.7M13.06%1.79B18.07%491.9M10.34%421.4M9.04%447.5M-1.81%428.4M
Research and development costs 2.49%1.08B-1.25%267.7M10.77%280.7M1.62%276.2M-0.82%254.6M9.36%1.05B11.98%271.1M4.37%253.4M11.53%271.8M-1.72%256.7M
Other operating expenses -22,300.00%-67.2M37.00%-14.3M-155.80%-12.5M---21.3M---19.1M---300K---22.7M--22.4M--------
Operating profit 10.55%1.64B4.81%370.3M7.81%425.1M15.03%430.9M14.53%409.9M-0.41%1.48B-0.95%353.3M7.12%394.3M-2.57%374.6M-17.27%357.9M
Net non-operating interest income expense 47.66%148.4M-18.78%35.9M58.85%38.6M141.29%37.4M121.21%36.5M102.62%100.5M163.10%44.2M60.93%24.3M70.33%15.5M91.86%16.5M
Non-operating interest income 40.32%168.8M-12.03%56.3M58.85%38.6M141.29%37.4M----79.02%120.3M86.05%64M60.93%24.3M70.33%15.5M----
Non-operating interest expense 3.03%20.4M----------------12.50%19.8M----------------
Total other finance cost -----------------121.21%-36.5M-----------------91.86%-16.5M
Other net income (expense) -1,474.46%-511.7M-4,167.57%-315.8M-629.75%-115.3M-1,016.39%-68.1M-290.63%-12.5M80.11%-32.5M-17.46%-7.4M-459.09%-15.8M94.85%-6.1M92.49%-3.2M
Gain on sale of security -93.50%4M----------------561.29%61.5M----------------
Special income (charges) -411.74%-518.9M-683.78%-319M-170.02%-118M-724.69%-66.8M-69.66%-15.1M42.81%-101.4M-311.11%-40.7M-1,886.36%-43.7M93.31%-8.1M79.86%-8.9M
-Less:Restructuring and merger&acquisition -89.18%6.6M-62.28%10.6M-137.69%-12.4M--4.2M--4.2M332.82%61M--28.1M--32.9M--0--0
-Less:Impairment of capital assets --40M--0--40M----------0--0--0--------
-Less:Other special charges 705.45%325.4M1,555.56%208.6M737.04%90.4M91.36%15.5M22.47%10.9M-80.15%40.4M27.27%12.6M390.91%10.8M-94.52%8.1M-79.54%8.9M
-Write off --146.9M--99.8M--0--47.1M------0--0--0--0----
Other non- operating income (expenses) -56.76%3.2M97.16%-800K-90.32%2.7M-165.00%-1.3M-54.39%2.6M60.87%7.4M-394.74%-28.2M322.73%27.9M-20.00%2M256.25%5.7M
Income before tax -17.78%1.27B-76.83%90.4M-13.51%348.4M4.22%400.2M16.89%433.9M12.80%1.55B6.24%390.1M3.92%402.8M39.59%384M-6.87%371.2M
Income tax 42.60%216.9M-41.91%26.2M37.84%56.1M221.50%64.3M51.84%70.3M-0.20%152.1M32.26%45.1M-22.77%40.7M-4.31%20M-20.31%46.3M
Net income -74.35%1.07B-76.27%91.2M-90.54%290.3M-9.18%331.5M1.54%356.4M197.96%4.17B3.95%384.3M699.95%3.07B19.48%365M3.08%351M
Net income continuous Operations -24.36%1.06B-81.39%64.2M-19.28%292.3M-7.72%335.9M11.91%363.6M14.43%1.4B3.57%345M8.12%362.1M43.19%364M-4.58%324.9M
Net income discontinuous operations -99.52%13.4M-31.30%27M-100.07%-2M-540.00%-4.4M-127.59%-7.2M1,446.10%2.77B7.38%39.3M5,447.75%2.71B-98.05%1M--26.1M
Minority interest income 16.33%-4.1M042.86%-800K30.77%1.7M-77.78%-1.6M-63.33%-4.9M-550.00%-1.3M-16.67%-1.4M181.25%1.3M-900K
Net income attributable to the parent company -74.28%1.07B-76.35%91.2M-90.52%291.1M-9.32%329.8M1.73%358M197.68%4.17B4.24%385.6M697.82%3.07B18.43%363.7M3.35%351.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -74.28%1.07B-76.35%91.2M-90.52%291.1M-9.32%329.8M1.73%358M197.68%4.17B4.24%385.6M697.82%3.07B18.43%363.7M3.35%351.9M
Basic earnings per share -73.64%1.84-75.38%0.16-90.27%0.5-6.56%0.575.17%0.61202.16%6.986.56%0.65715.87%5.1419.61%0.613.57%0.58
Diluted earnings per share -73.74%1.83-75.38%0.16-90.25%0.5-6.56%0.575.17%0.61203.04%6.976.56%0.65714.29%5.1322.00%0.613.57%0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More